Target intelligence / Profile preview

Smoothened (SMO)

Target: SMO
Molecular classification: G protein-coupled receptor, Class Frizzled GPCR

Overview

Smoothened (SMO) is a transmembrane protein and a member of the Class Frizzled (Class F) G protein-coupled receptor (GPCR) family. It plays an essential role in the Hedgehog (Hh) signaling pathway, which is crucial for embryonic development, tissue patterning, and adult tissue homeostasis. Dysregulation of Hedgehog/SMO signaling can result in developmental disorders or contribute to oncogenesis, such as basal cell carcinoma and medulloblastoma.

Mechanism of action

SMO antagonists inhibit SMO, preventing activation of the Hedgehog pathway.

Biological functions

Signal transductionEmbryonic developmentTissue homeostasis

Disease associations

CancerDevelopmental disorders

Safety considerations

Resistance to SMO inhibitors due to secondary mutations

Interacting drugs

Cyclopamine

2 more in the full profile.

Beyond the preview

Go deeper on Smoothened (SMO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smoothened (SMO).